PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer's disease

Journal of Alzheimer's Disease : JAD
Marina SaresellaMario Clerici

Abstract

Regulatory T lymphocytes (Treg) play a fundamental importance in modulating the relative balance between inflammation and immune tolerance, and alterations of these cells are observed in inflammatory diseases. To better characterize the neuroinflammatory processes suggested to be associated with Alzheimer's disease (AD) and to clarify the possible role of Treg cells in this process, we extensively analyzed these cells (CD4 + CD25highFoxp3+) in patients with either severe AD (n=25) or mild cognitive impairment (MCI) (n=25), comparing the results with those of two groups of healthy controls (HC) (n=55). Because the intra- or extracellular expression of programmed death receptor 1 (PD1) identifies functionally diverse subsets of Treg we also analyzed such subpopulations. Results showed that, whereas both Treg and PD1pos Treg are increased in MCI and AD patients compared to HC, PD1neg Treg, the subpopulation of Treg cells endowed with the strongest suppressive ability, are significantly augmented in MCI patients alone. In these patients amyloid-β-stimulated-T cells proliferation was reduced and Treg-mediated suppression was more efficient compared to both AD and HC. The observation that PD1neg Treg, cells are increased in MCI patie...Continue Reading

Citations

Nov 13, 2012·EMBO Molecular Medicine·Jenny S HenkelStanley H Appel
May 31, 2014·Stem Cells International·Andrea FariniYvan Torrente
May 11, 2017·Journal of Neuroscience Research·Samuel S DuffyGila Moalem-Taylor
Jan 14, 2017·Seminars in Immunopathology·Arya BiragynEvgeny Rogaev
Dec 21, 2017·Immunotherapy·Nyanbol KuolVasso Apostolopoulos
Aug 18, 2012·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Feng He, Rudi Balling
Feb 10, 2018·Translational Neurodegeneration·Xiaoguang DuMeiyu Geng
Dec 3, 2014·Journal of Neuroinflammation·Hugo González, Rodrigo Pacheco
Nov 2, 2015·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Howard E Gendelman, R Lee Mosley
Oct 9, 2016·Aging Clinical and Experimental Research·F GuerrieroG Ricevuti
Mar 24, 2015·Bioscience Reports·Imran UllahGyu Jin Rho
Apr 13, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Antero SalminenAnu Kauppinen
May 11, 2015·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Róisín M McManusMarina A Lynch
May 21, 2015·PloS One·Shigeaki InoueE Wesley Ely
Mar 6, 2017·Alzheimer's Research & Therapy·Róisín M McManus, Michael T Heneka
Aug 18, 2018·Alzheimer's Research & Therapy·Sudhanshu AgrawalAnshu Agrawal
Aug 17, 2019·World Journal of Clinical Cases·Emel Koseoglu
Mar 29, 2020·Brain and Neuroscience Advances·Caitlín Ní Chasaide, Marina A Lynch
Feb 26, 2016·Brain : a Journal of Neurology·Cira DansokhoGuillaume Dorothée
Jun 20, 2018·Frontiers in Immunology·Timo Jan ObersteinJuan Manuel Maler
May 28, 2019·Journal of Alzheimer's Disease : JAD·Yahui WuFang Liu
Jan 30, 2020·Frontiers in Immunology·Yan-Mei HuangHai-Lu Zhao
Jun 11, 2020·Clinical Proteomics·Cristina M Pedrero-PrietoYoana Rabanal-Ruiz
Aug 28, 2016·Science China. Life Sciences·Xu HuFeng Jin
May 21, 2018·Cellular and Molecular Life Sciences : CMLS·Antero SalminenAnu Kauppinen
Oct 5, 2018·Molecular Neurodegeneration·Wei Cao, Hui Zheng
May 24, 2019·Journal of Neuroinflammation·Francesco AngelucciJakub Hort
Dec 31, 2019·Journal of Immunology Research·Mohammed AlghamdiElrashdy M Redwan
Sep 22, 2020·Brain Communications·Alireza FaridarStanley H Appel
Dec 20, 2018·Frontiers in Neurology·Adonis SferaCarolina Osorio
Jun 9, 2020·Journal of Neuroinflammation·Marina SaresellaMario Clerici
Dec 17, 2020·Frontiers in Immunology·André J EsgalhadoFernando A Arosa
Feb 4, 2021·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Mingchao ShiJie Zhu
Mar 27, 2018·Journal of Neuroimmunology·Tomomi KiyotaHoward E Gendelman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.